LGI1 and myeloid sarcoma: Significant changes in β-diversity between patients with autoimmune neurological disorders and healthy individuals were reported in 4 out of 5 studies on anti-NMDAR encephalitis, 1 study on anti-LGI1 encephalitis, 5 out of 7 studies on MG, all 7 studies on NMOSD, 21 out of 34 studies on MS, 1 study on NBD, and 1 study on DON.